Amyloid β protein (globular assembly and uses thereof)

Details Amyloid β protein (globular assembly and uses thereof) Amyloid β protein (globular assembly and uses thereof)

2005-05-16

2009-12-29

Audet, Maury (Department: 1654)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C514S002600, C424S001690

Reexamination Certificate

active

07638283

ABSTRACT:
The invention described in this disclosure involves a new composition of matter, amyloid beta-derived dementing ligands (ADDL's). ADDLs consist of amyloid β peptide assembled into soluble globular non-fibrillar oligomeric structures that are capable of activating specific cellular processes. The invention further encompasses methods for assaying the formation, presence, receptor protein binding and cellular activities of ADDLs. The invention further encompasses assay methods and inhibitor molecules for cellular signaling molecules activated by ADDLs. Also described are molecules that block proteins that promote the formation of ADDLs.

REFERENCES:
patent: 6218506 (2001-04-01), Krafft et al.
patent: WO 9410569 (1994-05-01), None
Namgung et al. ‘Long Term Potentiation in Vivo in the Intact Mouse Hippocampus’, Brain Research, vol. 689, pp. 85-92, 1995.
Levine, Harry, ‘Soluble Multimeric Alzheimer .Beta. (1-40) Pre-Amyloid Complexes in Dilute Solution’, Neurobiology of Aging, vol. 16, No. 5, pp. 755-764, 1995.
Database CAPLUS on STN. No. 1993:623304. Chauhan et al. ‘Dual Modulation of Protein Kinase C Activity by Amyloid Beta-Protein’, abstract, 1993.
Roher et al. (Biochem., 90, 10836-10840) (both cited in the IDS of Dec. 10, 2007 (cited in applicant's IDS).
Kuo, Yu-Min, Emmerling, Mark R., Vigo-Pelfrey, Carmen, Kasunic, Timothy C., Kirkpatrick, Joel B., Murdoch, Geoffrey H., Ball, Melvyn J., Roher, Alex E., (1996). Water-soluble Aβ (N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains.The Journal of Biological Chemistry, 271(8), 4077-4081.
Roher, Alex E., Lowenson, Jonathon, D., Clarke, Steven, Woods, Amina S., Cotter, Robert J., Gowing, Eric, Ball, Melvyn, J. (1993). β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implication for the pathology of Alzheimer disease.Biochemistry, 90, 10836-10840.
Roher, Alex E., Chaney, Michael O., Kuo, Yu-Min, Webster, Scott D., Stine, W. Blaine, Haverkamp, Lanny J., Woods, Amina S., Cotter, Robert J., Thouhy, James M., Krafft, Grant A., Bonnell, Barry S., Emmerling, Mark R., (1996) Morphology and toxicity of Aβ-(1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease.The Journal of Biological Chemistry, 271(34), 20631-20635.
Wisniewski, T., Ghiso, J., Frangione, B., (1994). Alzheimer's Disease and Soluble Aβ.Neurobiology of Aging, 15(2), 143-152.
Busciglio, J., Lorenzo, A., Yeh., J., and Yanker, B.A. (1995). β-Amyloid Fibrils Induce Tau Phosphorylation and Loss of Microtubule Binding.Neuron14, 879-888.
Cal, X.D., Golde, T.E., and Younkin, S.G. (1993). Release Of Excess Amyloid Beta Protein From a Mutant Amyloid Beta Protein Precursor.Science259, 514-516.
Chartier-Harlan, M.C., Crawford, F., Houlden, H., Warren, A., Hughes, D., et al (1991) Early-onset Alzheimer's Disease Caused by Mutations at Codon 717 of the β-Amyloid Precursor ProteinNature, 353, 844-6.
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., Selkoe, D. (1992). Mutation Of the Amyloid Precursor Protein in Familial Alzheimer's Disease Increases Beta Protein Production.Nature360, 672-674.
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., Ward, P. J. (1990). Cleavage Of Amyloid Beta Peptide During Constitutive Processing Of Its PrecursorScience248, 1122-1124.
Glenner, G. G., and Wong, C. W. (1984a). Alzheimer's Disease Initial Report Of the Purification and Characterization Of a Novel Cerebro Vascular Amyloid.Biochem Biophys Res Commun120, 885-890.
Glenner, G. G., and Wong, C. W. (1984b). Alzheimer's Disease and Downs Syndrome Sharing Of a Unique Cerebrovascular Amyloid Fibril Protein.Biochem Biophys Res Commun122, 1131-1135.
Goate, A., Chartier-Harlen, M. C., Mullen, M., Brown, J., Crawford, F., et at (1991) Segregation of a Missense Mutation in the Amyloid Precursor Protein Gene with Familial Alzheimer's Disease.Nature, 349, 704-6.
Iversen, L. L, Mortishire-Smith, R. J., Pollack, S. J., Shearman, M. S. (1995). The toxicity in vitro of β-amyloid protein.Biochem311, 1-16.
Kang, J., Lemaire, H.G., A. Unterbeck, J. Salbaum, C. Masters, K.-H. Grzeschik, G. Multhaup, K. Beyreuther, B. Muller-Hill (1987)Nature325, 733-736.
Ladror, U. S., Snyder, S. W., Wang, G. T., Holzman, T. F., Krafft, G. A. (1994) “Cleavage at the Amino and Carboxy Termini of Alzheimer's Amyloid-β by Cathepsin D”J. Biol. Chem. 269, 18422-8.
Ladu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., Frail, D. E. lsoform-Specific Binding of Apolipoprotein-E to Beta-Amyloid. (1994)J. Biol. Chem. 269, 23403-23406.
Ladu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., and Frail, D. E. (1994) Purification of Apolipoprotein-E Attenuates Isoform-Specific Binding to Beta-Amyloid.J. of Biol. Chem. 269, 9039-9042.
Lambert, M. P., Stevens, G., Sabo, S., Barber, K., Wang, G., Wade, W., Krafft, G., Snyder, S., Holzman, T. F., Klein, W. L. (1994) b/A4-Evoked Degeneration of Differentiated SH-Sy5Y Human Neuroblastoma Cells.J. Neurosci. Res. 39, 377-384.
Levy-Lahad E., Wijsman EM, Nemens E, Anderson L, Goddard Kab, Weber JL, Bird TD, Schellenberg GD (1995) a Familial Alzheimer's Disease Locus on Chromosome 1.Science269: 970-973.
Lorenzo, A., and Yankner, B. A. (1994). β-Amyloid neurotoxicity requires fibril information and is inhibited by Congo red.Proc Natl Acad Sci91, 12243-12247.
Ma J, Yee A, Brewer HB, Das S and Potter H (1994) The amyloid-associated proteins a1-antichymotrypsin and apolipoprotein E promote the assembly of the Alzheimer β-protein into filaments.Nature372: 92-94.
Mann, D. M., lwatsubo, T., Cairns, N. J., Lantos, P. L., Nochlin, D., Sumi, S. M., Bird, T. D., Poorkaj, P., Hardy, J., Hutton, M., Prihar, G., Crook, R., Rossor, M. N., and Haltia, M. (1996). Amyloid beta protein (Abeta) deposition in chromosome, 14-linked Alzheimer's disease: predominance of Abeta42(43).Annals of Neurology40, 149-56.
Masters, C.L., Multhaup, G., Simms, G., Pottgiesser, J., and Martins, R. (1985a). Neuronal Origin Of a Cerebral Amyloid. Neurofibrillary Tangles Of Alzheimer's Disease Contain the Same Protein As the Amyloid Of Plaque Cores and Blood Vessels.EMBOJ. 4, 2757-2764.
Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., and McDonald, B. (1985b). Amyloid Plaque Core Protein In Alzheimer's Disease and Down Syndrome.Proc Natl Acad SciU S A 82, 4245-4249.
May, P. C., Gitter, B. D., Waters, D. C., Simmons, L. K., Becker, G. W., Small, J. S., and Robison, P. M. (1992). β-Amyloid Peptide In Vitro Toxicity: Lot-to-Lot Variability.Neurobiol Aging13, 605-607.
Mullan, M., Crawford, F. Axelman, K., Houlden, H., Lilius, L. Winblad, B., Lannfelt, L. (1992) A Pathogenic Mutation for Probable Alzheimer's-Disease in the APP Gene at the N-Terminus of Beta-Amyloid. Nature Genetics 1, 345-347.
Murrell, J. Farlow M., Ghetti, B., and Benson, M.D. (1991). A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease.Science, 254, 97-9.
Namgung, U., Valcourt, E., Routtenberg A. (1995). Long-term potentiation in vivo in the intact mouse hippocampus.Brain Research689, 85-92.
Oda, T., Pasinetti, G. M., Osterburg, H. H., Anderson, C., Johnson, S.A., Finch, C.E. (1994). Purification and Characterization of Brain Clusterin.Biochem. Biophys. Res. Commun., 204, 1131-1136.
Oda, T., Pasinetti, G. M., Stine, W. B., Snyder, S. W., Holzman, T. F., Krafft, G. A., Osterburg, H. H., Johnson, S. A., Finch, C. E. (1995). Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ1-42) and Forms Slowly Sedimenting Aβ/Clusterin complexes that cause Oxidative StressExptl. Neurology, 136, 22-31.
Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G., and Cotman, C. W. (1993). Neurodegeneration Induced by β-Amyloid Peptides in vitro: The Role of Peptide Assembly State.The Journal of Neuroscience13(4), 1676-1687.
Roher, A. E., Palmer, K.C., Yurewicz, E. C., Ball, M. J., Greenb

Affiliated with

Also associated with

Rating

Amyloid β protein (globular assembly and uses thereof) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amyloid β protein (globular assembly and uses thereof), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amyloid β protein (globular assembly and uses thereof) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4104105